Quantcast

Latest Adverse effect Stories

2014-03-14 12:28:50

LEXINGTON, Massachusetts, March 14, 2014 /PRNewswire/ -- Shire Pharmaceuticals announced today the initiation of a voluntary recall in the United States of one batch, packaged into three lots, of VPRIV due to the presence of visible particulate matter, identified as stainless steel and barium sulfate. The particulate matter was found in a small number of vials in the three packaged lots of VPRIV. A Shire investigation identified the particulate matter root cause as the third...

2014-03-13 17:18:53

Investigators call on drug regulators to provide clear evidence to patients on claims of drug side effects At a time when the wider prescription of statins is under renewed public scrutiny, a substantial analysis of placebo-controlled randomised trials of statins has found that only a small minority of side effects reported by those taking the cholesterol-lowering drugs are actually attributable to them. Almost all the side effects reported in these trials "occurred anyway when patients...

2014-03-10 23:01:48

With Pradaxa Lawsuit Mounting, A Recently Published Study Indicates The FDA Received More Complaints About The Blood Thinner Pradaxa Than Any Other Prescription Drug Over A Two Year Period Columbus, OH (PRWEB) March 10, 2014 As Pradaxa Lawsuits continue to be filed (MDL 2385), lawyers at Wright & Schulte LLC are reviewing the findings of a recently released study found the blood thinner Pradaxa to be the most complained about prescription drug in the United States. This Pradaxa study...

2014-03-04 16:26:01

PLEASANTON, Calif., March 4, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II(®) LVAS Pocket System Controller (the "Pocket Controller"). This safety advisory is being issued because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These...

2014-03-03 23:01:27

Scott A. Norton, MD, MPH, chief of dermatology at Children’s National Health System, and two medical students working with him identified improper sales of antibiotics without prescriptions in neighborhood grocery stores in the Washington, DC, area. Washington, DC (PRWEB) March 03, 2014 Scott A. Norton, MD, MPH, chief of dermatology at Children’s National Health System, and two medical students working with him identified improper sales of antibiotics without prescriptions in...

2014-02-27 12:27:13

bioCSL Inc. initiates 2014-15 season pre-booking for AFLURIA® (Influenza Vaccine) KING OF PRUSSIA, Pa., Feb. 27, 2014 /PRNewswire/ -- CSL Biotherapies Inc. announced today it has changed its name to bioCSL Inc., effective February 21, 2014. This change is pursuant to the Australian, New Zealand and German renaming of the company, which occurred one year ago. In September 2013, bioCSL was the first United States supplier to complete its 2013-14 seasonal influenza vaccine delivery...

2014-02-14 16:25:50

BEDFORD, Ohio, Feb. 14, 2014 /PRNewswire/ -- Ben Venue Laboratories, Inc. today issued a nationwide voluntary product recall: Acetylcysteine Solution 10%, USP, (Manufactured for Roxane Laboratories, Inc.) 10%, 30 mL per vial - NDC #0054-3025-02 - Lot 2005479 - Exp. Date March 2014 This voluntary recall was initiated on February 14, 2014 after the discovery of a single visible glass particle in a vial within the lot listed above. There have been no complaints or adverse events related to a...

2014-02-14 08:26:37

LEXINGTON, Massachusetts, February 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food & Drug Administration (FDA) has approved the production of VPRIV(R) drug substance (velaglucerase alfa for injection) in Shire's manufacturing facility at 400 Shire Way, Lexington, Massachusetts, US. The facility was previously approved by the European Medicines Agency (EMA) for production of VPRIV...

2014-02-04 20:23:48

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wnzm6k/therapeutic_drug) has announced the addition of the "Concise Analysis on the International Therapeutic Drug Monitoring Markets" [http://www.researchandmarkets.com/research/wnzm6k/therapeutic_drug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Therapeutic drug monitoring (TDM) is an important clinical assessment...

2014-01-23 23:20:20

Additional post-market surveillance is required to accurately determine potential risks of products containing caffeine. Minneapolis, MN (PRWEB) January 23, 2014 SafetyCall International today issued a statement in response to the Institute of Medicine’s (IOM) report released last week, “Examining Safety: Workshop Summary of Caffeine in Food and Dietary Supplements.” SafetyCall’s President of Regulatory and Scientific Affairs Dr. Richard Kingston, who participated in the workshop,...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related